Country: United States
Language: English
Source: NLM (National Library of Medicine)
CHLOROQUINE PHOSPHATE (UNII: 6E17K3343P) (CHLOROQUINE - UNII:886U3H6UFF)
Rising Pharmaceuticals, Inc.
CHLOROQUINE PHOSPHATE
CHLOROQUINE PHOSPHATE 250 mg
ORAL
PRESCRIPTION DRUG
Chloroquine phosphate is indicated for the: - Treatment of uncomplicated malaria due to susceptible strains of P. falciparum, P.malariae, P. ovale, and P.vivax . - Prophylaxis of malaria in geographic areas where resistance to chloroquine is not present. - Treatment of extraintestinal amebiasis. Chloroquine phosphate tablets do not prevent relapses in patients with vivax or ovale malaria because it is not effective against exoerythrocytic forms of the parasites. Limitations of Use in Malaria: - Do not use chloroquine phosphate tablets for the treatment of complicated malaria (high-grade parasitemia and/or complications e.g., cerebral malaria or acute renal failure). - Do not use chloroquine phosphate tablets for malaria prophylaxis in areas where chloroquine resistance occurs, Resistance to chloroquine phosphate tablets is widespread in P. falciparum , and is reported in P.vivax (see WARNINGS). - Concomitant therapy with an 8-aminoquinoline drug is necessary for treatment of the hypnozoite liver stage form
Tablets containing 250 mg chloroquine phosphate USP, equivalent to 150 mg of chloroquine base Bottle of 50 (NDC 64980-177-50) Bottle of 100 (NDC 64980-177-01) Bottle of 500 (NDC 64980-177-05) Bottle of 1000 (NDC 64980-177-10) Chloroquine phosphate tablets are white to off-white colour round, bi-convex tablets, debossed with 'CN 250' on one side and score line on the other side. Dispense in tight, light-resistant container as defined in the USP/NF. Store at 20-25°C (68-77° F) [See USP Controlled Room Temperature]. Protect from light and moisture.
Abbreviated New Drug Application
CHLOROQUINE PHOSPHATE - CHLOROQUINE PHOSPHATE TABLET RISING PHARMACEUTICALS, INC. ---------- CHLOROQUINE PHOSPHATE TABLET, USP DESCRIPTION Chloroquine phosphate tablets 250 mg, chloroquine phosphate, USP, is a 4-aminoquinoline compound for oral administration. It is a white, odorless, bitter tasting, crystalline substance, freely soluble in water. Chloroquine phosphate is an antimalarial and amebicidal drug. Chemically, it is 7-chloro-4-[[4- (diethylamino)-1-methylbutyl]amino] quinoline phosphate (1:2) and has the following structural formula: Each tablet contains 250 mg of chloroquine phosphate USP, equivalent to 150 mg chloroquine base. _Inactive Ingredients:_ Colloidal silicon dioxide, dibasic calcium phosphate, magnesium stearate, microcrystalline cellulose, pregelatinized starch and sodium starch glycolate. CLINICAL PHARMACOLOGY Chloroquine is rapidly and almost completely absorbed from the gastrointestinal tract, and only asmall proportion of the administered dose is found in the stools. Approximately 55% of the drug inthe plasma is bound to nondiffusible plasma constituents. Excretion of chloroquine is quite slow,but is increased by acidification of the urine. Chloroquine is deposited in the tissues in considerableamounts. In animals, from 200 to 700 times the plasma concentration may be found in the liver,spleen, kidney, and lung; leukocytes also concentrate the drug. The brain and spinal cord, incontrast, contain only 10 to 30 times the amount present in plasma. Chloroquine undergoes appreciable degradation in the body. The main metabolite isdesethylchloroquine, which accounts for one fourth of the total material appearing in the urine;bisdesethylchloroquine, a carboxylic acid derivative, and other metabolic products as yetuncharacterized are found in small amounts. Slightly more than half of the urinary drug productscan be accounted for as unchanged chloroquine. MICROBIOLOGY Mechanism of Action: Chloroquine, a 4-aminoquinoline, is an anti-protozoal agent. The precise mechanism by which chloroquine exhib Read the complete document